| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |